April 6, 2017 09:56 AM EDT
News Briefing

Adap­ti­m­mune rais­es $106M for pipeline work; Kalo­Bios chief says biotech is on track for Cha­gas drug fil­ing

Shehla Shakoor

Managing Director

→ Ma­trix Cap­i­tal Man­age­ment has scooped up $42 mil­lion worth of Adap­ti­m­mune stock $ADAP, pay­ing a slight pre­mi­um for the block of shares. We …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times